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Introduction
Infection with Cryptococcus neoformans is a universal
problem of increasing importance. The incidence of rec-
ognized clinical cases is increasing, as immunosuppres-
sion becomes more widespread, and as clinical awareness
of this disease increases. Immunocompromised patients
with disseminated cryptococcosis usually present with
either pulmonary or central nervous system involve-
ment. In addition, cutaneous involvement is a rare but
important feature of disseminated cryptococcosis, which
has a piteous outcome if unrecognized and untreated.
We report a case of cryptococcal cellulitis in a patient
with rheumatoid arthritis (RA) who received long-term
steroid treatment. As demonstrated in this case, diag-
nostic skin biopsy aids in early diagnosis and treatment.
Case Report
This 76-year-old male was diagnosed with RA and dia-
betes mellitus (DM) and was on methylprednisolone
and hypoglycemic treatments since 4 years before this
presentation. The dose of methylprednisolone he was
using at admission was 12 mg/day. His RA was initially
diagnosed by subcutaneous rheumatoid nodules, a high
serum level of rheumatoid factor, morning stiffness of
bilateral upper extremities and typical X-ray findings
in the juxta-articular bones of both hands.
In March 2006, he was hospitalized with a 1-month
history of progressive swelling, erythema, induration,
tenderness and ulceration on the medioposterior aspect
of the left lower leg (Figure 1). The patient denied fever,
shaking chills, night sweating, cough, sputum produc-
tion, chest pain, or dyspnea. There was no history of
pigeon exposure, antecedent bronchitis, pharyngitis,
otitis, visual difficulty, or headache. Abnormal laboratory
tests included white blood cell count 10,000/mm3
with 94% polymorphonuclear leukocytes, C-reactive
protein 3.20 mg/dL and creatine kinase 35 U/L.
General biochemistry tests including liver and renal
functions were normal. Urinalysis was unremarkable.
Antibody to human immunodeficiency virus was nega-
tive. The initial chest X-ray revealed a normal finding.
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Left lower leg X-ray disclosed only soft tissue swelling,
but no bone destruction. Immediately, the patient was
treated parenterally with oxacillin, and the methylpred-
nisolone was discontinued simultaneously for fear of
immunosuppression. Nevertheless, the area of cellulitis
progressed gradually. So, an ultrasound of the lower
limb was performed, which showed no evidence of arte-
rial insufficiency or deep vein thrombosis. Three-phase
osteomyelitis scan of the left lower leg showed a negative
result.
On the 5th day after hospitalization, a newly devel-
oped round rubbery mass on the medial aspect of the
left upper arm was noted (Figure 2). Skin biopsy and
culture of the left upper arm mass and left leg lesion
were done. These 2 lesions proved to be infected with
Cryptococcus neoformans (Figure 3). Meanwhile, the
blood culture also grew Cryptococcus neoformans, which
was sensitive to fluconazole and amphotericin-B. Flu-
conazole was added because of its lower nephrotoxicity
than amphotericin-B. Due to productive cough with
yellowish sputum, chest X-ray was taken 16 days after
admission. It revealed a new patch lesion over the right
lower lung field. Under the suspicion of disseminated
cryptococcosis, lumbar puncture was performed, and
the cerebrospinal fluid culture was also positive for
Cryptococcus neoformans. Furthermore, latex aggluti-
nation to cryptococcus in serum was positive, with a
titer > 1:1,024. Under the diagnosis of disseminated
cryptococcosis, amphotericin-B was prescribed to re-
place fluconazole 4 weeks after admission. We pre-
scribed amphotericin-B 16 mg as the test dose on the
1st day and increased the dose to 20 mg every night
over the following 7 days. Thereafter, amphotericin-B
25 mg every night was applied over the following 
15 days until we discontinued amphotericin-B. The
patient’s left leg cellulitis improved significantly. Mean-
while, 2 sets of blood culture 6 weeks after admission
grew no fungus or bacteria. Thus, amphotericin-B
was stopped after a total of 8 weeks of treatment with
amphotericin-B and fluconazole.
However, fever and comatous consciousness oc-
curred 3 days after we discontinued amphotericin-B.
The patient did not take opiates or alcohol. There 
was no electrolyte imbalance or trauma. The repeated
blood glucose levels were within normal limits. Brain
computed tomography showed only periventricular
arteriosclerotic encephalopathy. Hence, we speculated
that sepsis was the main cause of comatous conscious-
ness. Empirical treatment with ceftazidime was given
immediately. Unfortunately, he suffered acute respi-
ratory failure and septic shock. His sputum culture
then grew yeast, Pseudomonas aeruginosa and Klebsiella
pneumoniae. So, we prescribed amphotericin-B again,
as well as shifted ceftazidime to maxipime and 
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Figure 1. An area of subcutaneous swelling, erythema, desqua-
mation, induration and shallow ulcers in the left lower leg.
Figure 2. A round rubbery mass with central ulceration and periph-
eral erythematous induration noted over the left upper arm.
Figure 3. Combined Alcian blue–periodic acid-Schiff stain of skin
specimen reveals typical acidic capsule and neutral mucosubstance
of Cryptococcus neoformans.
vancomycin. We used amphotericin-B 20 mg every
night for 9 days until the patient died. The total 
accumulated amphotericin-B dose was 711 mg.
During his admission, persistent anorexia and painful
oral ulcers were noted. Although nasogastric feeding and
intravenous albumin supplement were given, he still
had a very low serum albumin level (1.5g/dL in the 8th
week of admission, initial serum albumin was 4.1g/dL).
Finally, he expired in the 10th week of admission.
Discussion
Impaired lymphocyte response to cryptococci, especially
in immunocompromised hosts with T cell dysfunction,
is noted in most patients with cryptococcal infection.1
The depletion of CD4+T lymphocytes may decrease
the ability to eliminate them and increase the possibil-
ity of dissemination. This may explain the increased
incidence of cryptococcosis in immunocompromised
hosts.2 RA is a chronic inflammatory disease of the
synovium, which is associated with many phenotypic
and functional T lymphocyte defects, including ab-
normal clonal expansions and suppressed proliferative
responses, suggesting a defect in T lymphocyte dif-
ferentiation.3 Additionally, RA patients usually need
prolonged immunosuppressive treatment, which also
increases the risk of infection.4 So it is little wonder 
to find Cryptococcus neoformans infection in our RA
patient with long-term steroid treatment.
Cryptococcus neoformans is a non-mycelial encap-
sulated budding yeast. The most common exposure
sources are inhalation of aerosolized infectious yeast
from pigeon, avian excreta, contaminated soil, milk,
fruits, and wood products. Patients usually present with
pneumonia, and Cryptococcus neoformans consequently
spreads to the central nervous system.5,6 However, our
case did not have symptoms of pneumonia, such as
cough, sputum production, chest pain or dyspnea. His
initial chest X-ray was unremarkable. Conversely, his
initial infection site was cellulitis of the left lower leg.
Cutaneous cryptococcal disease usually represents
the hematogenous dissemination of cryptococcosis.7
Cryptococcal skin involvement usually manifest as
ulcers, acneiform papules or pustules, subcutaneous
swellings or tumors, ecchymoses, granulomata, gum-
mas, abscesses, vesicles, palpable purpura, papules, or
cellulitis.8 We performed a MEDLINE search of the
literature from 1966 to the present and found no case
of RA with disseminated cryptococcosis that initially
presented as cellulitis.
The cryptococcal skin infection of our case 
was specifically diagnosed with a combined Alcian
blue–periodic acid-Schiff stain and skin culture.8
Patients with cryptococcal cellulitis should be treated
as those with disseminated cryptococcosis. A prolonged
course (6–10 weeks) of intravenous monotherapy with
amphotericin-B can be used.9 Actually, fluconazole
and itraconazole, which are as effective as ampho-
tericin-B but with fewer adverse effects, can also be
used in cases with systemic and cutaneous cryptococ-
cal diseases.10–12 Although intravenous amphotericin-
B was replaced by fluconazole in our case due to
negative blood cultures and worry about deteri-
oration of renal function after a 4-week treatment, 
we kept on using fluconazole and amphotericin-B
alternately throughout his admission (> 8 weeks) due
to his high serum level of cryptococcal capsular 
antigen.
With appropriate systemic antifungal therapy, the
majority of patients (> 80%) with cryptococcal celluli-
tis can be expected to survive in immunocompetent
status. However, our case was immunocompromised
with RA, DM and a history of long-term steroid
treatment, and he finally expired due to septic shock.
A previous study showed that hypoalbuminemia was
correlated with high mortality in patients with pneu-
monia.13 The hypoalbuminemia of our case came
from chronic severe inflammation, sepsis and malnu-
trition. Also, we repeated urinalysis several times in
the whole treatment course. The initial urine survey
revealed negative results. However, urine protein loss
(spot urine protein, 100mg/dL) was confirmed by uri-
nalysis after septic shock took place, which coincided
with progressive deterioration of renal function and
exacerbated the hypoalbuminemia. Our case had painful
oral ulcers and anorexia during admission. Nasogastric
feeding and intravenous albumin supplement were
given, but the patient had persistent malnutrition, which
worsened his prognosis. In such circumstance, more
aggressive nutrition with total parenteral nutrition
should have been considered for our patient as early
as possible.
In conclusion, cryptococcal cellulitis is uncommon
and indistinguishable in presentation and appearance
from acute bacterial cellulitis.14 Furthermore, dis-
seminated cryptococcosis without treatment is nearly 
uniformly fatal, and appropriate systemic antifungal
therapy can significantly improve the outcome. Thus,
the physician must search for an unusual cause 
early if the cellulitis fails to respond to routine antibi-
otic treatment. Skin biopsy should be undertaken
promptly in such instances. A diagnostic skin culture
or biopsy may show characteristic organisms, as well
as make an immediate diagnosis and early treatment
possible.
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